Enhancing fibroblast activation protein (FAP)-targeted radionuclide therapy with albumin binding, and beyond.
作者信息
Younis Muhsin H, Malih Sara, Lan Xiaoli, Rasaee Mohammad Javad, Cai Weibo
机构信息
Departments of Radiology and Medical Physics, University of Wisconsin - Madison, Madison, WI, USA.
Department of Medical Biotechnology, Faculty of Medical Sciences, Tarbiat Modares University, Tehran, Iran.
出版信息
Eur J Nucl Med Mol Imaging. 2022 May;49(6):1773-1777. doi: 10.1007/s00259-022-05766-0.
Abstract
摘要
相似文献
1
Enhancing fibroblast activation protein (FAP)-targeted radionuclide therapy with albumin binding, and beyond.通过白蛋白结合增强成纤维细胞活化蛋白（FAP）靶向放射性核素治疗及其他应用。
Eur J Nucl Med Mol Imaging. 2022 May;49(6):1773-1777. doi: 10.1007/s00259-022-05766-0.
2
Fibroblast activation protein (FAP)-targeted radionuclide therapy: which ligand is the best?成纤维细胞活化蛋白（FAP）靶向放射性核素治疗：哪种配体最佳？
Eur J Nucl Med Mol Imaging. 2023 Aug;50(10):2935-2939. doi: 10.1007/s00259-023-06338-6.
3
Increased expression of fibroblast activation protein-alpha in keloid fibroblasts: implications for development of a novel treatment option.成纤维细胞激活蛋白-α在瘢痕疙瘩成纤维细胞中的高表达：为新型治疗选择的发展提供了依据。
Arch Dermatol Res. 2010 Dec;302(10):725-31. doi: 10.1007/s00403-010-1084-x. Epub 2010 Sep 26.
4
Fibroblast activation protein regulates tumor-associated fibroblasts and epithelial ovarian cancer cells.成纤维细胞激活蛋白调节肿瘤相关成纤维细胞和上皮性卵巢癌细胞。
Int J Oncol. 2012 Aug;41(2):541-50. doi: 10.3892/ijo.2012.1475. Epub 2012 May 14.
5
Specific inhibition of fibroblast activation protein (FAP)-alpha prevents tumor progression in vitro.成纤维细胞活化蛋白（FAP）-α的特异性抑制可阻止体外肿瘤进展。
Adv Med Sci. 2015 Sep;60(2):264-72. doi: 10.1016/j.advms.2015.04.006. Epub 2015 May 11.
6
Ultraviolet exposure of melanoma cells induces fibroblast activation protein-α in fibroblasts: Implications for melanoma invasion.黑色素瘤细胞的紫外线暴露诱导成纤维细胞中纤维母细胞激活蛋白-α的表达：对黑色素瘤侵袭的影响。
Int J Oncol. 2011 Jul;39(1):193-202. doi: 10.3892/ijo.2011.1002. Epub 2011 Apr 13.
7
Fibroblast activation protein-α-expressing fibroblasts promote the progression of pancreatic ductal adenocarcinoma.表达成纤维细胞活化蛋白-α的成纤维细胞促进胰腺导管腺癌的进展。
BMC Gastroenterol. 2015 Sep 2;15:109. doi: 10.1186/s12876-015-0340-0.
8
[FIBROBLAST ACTIVATION PROTEIN (FAP) AS A POSSIBLE TARGET OF THE ANTITUMOR STRATEGY.].[成纤维细胞活化蛋白（FAP）作为抗肿瘤策略的潜在靶点。]
Mol Gen Mikrobiol Virusol. 2016;34(3):90-97.
9
Theranostics Targeting Fibroblast Activation Protein in the Tumor Stroma: Cu- and Ac-Labeled FAPI-04 in Pancreatic Cancer Xenograft Mouse Models.肿瘤基质中成纤维细胞激活蛋白的治疗策略：胰腺癌细胞异种移植鼠模型中的 Cu-和 Ac 标记的 FAPI-04。
J Nucl Med. 2020 Apr;61(4):563-569. doi: 10.2967/jnumed.119.233122. Epub 2019 Oct 4.
10
Molecular recognition of fibroblast activation protein for diagnostic and therapeutic applications.成纤维细胞激活蛋白的分子识别及其在诊断和治疗中的应用。
Biochim Biophys Acta Proteins Proteom. 2020 Jul;1868(7):140409. doi: 10.1016/j.bbapap.2020.140409. Epub 2020 Apr 6.
引用本文的文献
1
Therapeutic potential of FAPI RLT in oncology: A systematic review.FAPI放射性配体疗法在肿瘤学中的治疗潜力：一项系统综述。
Theranostics. 2025 Mar 10;15(9):4084-4100. doi: 10.7150/thno.106108. eCollection 2025.
2
Design, preclinical evaluation, and first-in-human PET study of [Ga]Ga-PSFA-01: a PSMA/FAP heterobivalent tracer.[镓]Ga-PSFA-01的设计、临床前评估及首次人体PET研究：一种PSMA/FAP异二价示踪剂
Eur J Nucl Med Mol Imaging. 2025 Feb;52(3):1166-1176. doi: 10.1007/s00259-024-06965-7. Epub 2024 Nov 9.
3
Development and evaluation of albumin binder-conjugated heterodimeric radiopharmaceuticals targeting integrin αβ and CD13 for cancer therapy.靶向整合素 αβ 和 CD13 的白蛋白结合物缀合的异二聚体放射性药物用于癌症治疗的开发和评估。
Eur J Nucl Med Mol Imaging. 2024 Sep;51(11):3334-3345. doi: 10.1007/s00259-024-06766-y. Epub 2024 May 24.
4
Theranostics in targeting fibroblast activation protein bearing cells: Progress and challenges.靶向成纤维细胞激活蛋白阳性细胞的治疗学研究：进展与挑战。
Life Sci. 2023 Sep 15;329:121970. doi: 10.1016/j.lfs.2023.121970. Epub 2023 Jul 21.
5
Fibroblast activation protein (FAP)-targeted radionuclide therapy: which ligand is the best?成纤维细胞活化蛋白（FAP）靶向放射性核素治疗：哪种配体最佳？
Eur J Nucl Med Mol Imaging. 2023 Aug;50(10):2935-2939. doi: 10.1007/s00259-023-06338-6.
6
Head-to-head comparison of different classes of FAP radioligands designed to increase tumor residence time: monomer, dimer, albumin binders, and small molecules vs peptides.不同类别的 FAP 放射性配体的头对头比较：旨在增加肿瘤滞留时间的单体、二聚体、白蛋白结合物和小分子与肽。
Eur J Nucl Med Mol Imaging. 2023 Aug;50(10):3050-3061. doi: 10.1007/s00259-023-06272-7. Epub 2023 Jun 1.
7
Organotrifluoroborate enhances tumor targeting of fibroblast activation protein inhibitors for targeted radionuclide therapy.三氟硼酸盐增强成纤维细胞激活蛋白抑制剂的肿瘤靶向性用于放射性核素靶向治疗。
Eur J Nucl Med Mol Imaging. 2023 Jul;50(9):2636-2646. doi: 10.1007/s00259-023-06230-3. Epub 2023 Apr 27.
8
State-of-the-art of nuclear medicine and molecular imaging in China: after the first 66 years (1956-2022).中国核医学与分子影像的发展现状：66年（1956 - 2022年）回顾
Eur J Nucl Med Mol Imaging. 2022 Jul;49(8):2455-2461. doi: 10.1007/s00259-022-05856-z.
本文引用的文献
1
Efficacy and Safety of Ac-PSMA-617-Targeted Alpha Therapy in Metastatic Castration-Resistant Prostate Cancer: A Systematic Review and Meta-Analysis.Ac-PSMA-617靶向α治疗在转移性去势抵抗性前列腺癌中的疗效和安全性：一项系统评价和荟萃分析
Front Oncol. 2022 Feb 3;12:796657. doi: 10.3389/fonc.2022.796657. eCollection 2022.
2
Dimeric FAPI with potential for tumor theranostics.具有肿瘤诊疗潜力的二聚体FAPI
Am J Nucl Med Mol Imaging. 2021 Dec 15;11(6):537-541. eCollection 2021.
3
Fibroblast Activation Protein (FAP) targeting homodimeric FAP inhibitor radiotheranostics: a step to improve tumor uptake and retention time.靶向成纤维细胞活化蛋白（FAP）的同二聚体FAP抑制剂放射诊疗剂：提高肿瘤摄取和保留时间的一步。
Am J Nucl Med Mol Imaging. 2021 Dec 15;11(6):476-491. eCollection 2021.
4
Evans blue-modified radiolabeled fibroblast activation protein inhibitor as long-acting cancer therapeutics.埃文斯蓝修饰的放射性标记成纤维细胞活化蛋白抑制剂作为长效癌症治疗药物。
Theranostics. 2022 Jan 1;12(1):422-433. doi: 10.7150/thno.68182. eCollection 2022.
5
First clinical experience of 106 cm, long axial field-of-view (LAFOV) PET/CT: an elegant balance between standard axial (23 cm) and total-body (194 cm) systems.106厘米长轴视野（LAFOV）PET/CT的首次临床经验：标准轴向（23厘米）和全身（194厘米）系统之间的完美平衡。
Eur J Nucl Med Mol Imaging. 2021 Nov;48(12):3755-3759. doi: 10.1007/s00259-021-05505-x.
6
Rational Design, Pharmacomodulation, and Synthesis of [Ga]Ga-Alb-FAPtp-01, a Selective Tumor-Associated Fibroblast Activation Protein Tracer for PET Imaging of Glioma.[Ga]Ga-Alb-FAPtp-01 的合理设计、药效修饰及合成：一种用于 PET 成像胶质瘤的肿瘤相关成纤维细胞激活蛋白示踪剂
ACS Sens. 2021 Sep 24;6(9):3424-3435. doi: 10.1021/acssensors.1c01316. Epub 2021 Aug 20.
7
Feasibility and Therapeutic Potential of 177Lu-Fibroblast Activation Protein Inhibitor-46 for Patients With Relapsed or Refractory Cancers: A Preliminary Study.177Lu-成纤维细胞激活蛋白抑制剂-46用于复发或难治性癌症患者的可行性及治疗潜力：一项初步研究
Clin Nucl Med. 2021 Nov 1;46(11):e523-e530. doi: 10.1097/RLU.0000000000003810.
8
State-of-the-art of FAPI-PET imaging: a systematic review and meta-analysis.FAPI-PET 成像的最新技术：系统评价和荟萃分析。
Eur J Nucl Med Mol Imaging. 2021 Dec;48(13):4396-4414. doi: 10.1007/s00259-021-05475-0. Epub 2021 Jun 25.
9
Dynamic PET imaging with ultra-low-activity of F-FDG: unleashing the potential of total-body PET.超低活度F-FDG动态PET成像：释放全身PET的潜力
Eur J Nucl Med Mol Imaging. 2021 Dec;48(13):4138-4141. doi: 10.1007/s00259-021-05214-5.
10
The Latest Developments in Imaging of Fibroblast Activation Protein.成纤维细胞激活蛋白成像的最新进展。
J Nucl Med. 2021 Feb;62(2):160-167. doi: 10.2967/jnumed.120.244806. Epub 2020 Oct 30.
Zotero 插件